Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122811036 | 12281103 | 6 | F | 201604 | 20160808 | 20160419 | 20160816 | EXP | US-PFIZER INC-2016192610 | PFIZER | 74.00 | YR | M | Y | 108.84000 | KG | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122811036 | 12281103 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG ONCE DAILY, CYCLIC (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 122811036 | 12281103 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG ONCE DAILY, CYCLIC (1 WEEK ON/1 WEEK OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 122811036 | 12281103 | 3 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | UNK | 0 | |||||||||||
| 122811036 | 12281103 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 122811036 | 12281103 | 5 | C | CARVEDIOL | CARVEDILOL | 1 | UNK | 0 | |||||||||||
| 122811036 | 12281103 | 6 | C | CLONIDINE. | CLONIDINE | 1 | UNK | 0 | |||||||||||
| 122811036 | 12281103 | 7 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 122811036 | 12281103 | 8 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 122811036 | 12281103 | 9 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 122811036 | 12281103 | 10 | C | NOVOLOG | INSULIN ASPART | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122811036 | 12281103 | 1 | Metastatic renal cell carcinoma |
| 122811036 | 12281103 | 2 | Renal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122811036 | 12281103 | OT |
| 122811036 | 12281103 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122811036 | 12281103 | Asthenia | |
| 122811036 | 12281103 | Cardiac failure | |
| 122811036 | 12281103 | Full blood count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122811036 | 12281103 | 1 | 20160317 | 201604 | 0 | |
| 122811036 | 12281103 | 2 | 20160425 | 201608 | 0 |